Detalles de la búsqueda
1.
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting.
Rheumatol Int
; 39(9): 1547-1558, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321485
2.
Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast.
J Drugs Dermatol
; 17(10): 1078-1082, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30365588
3.
Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial.
Rheumatol Ther
; 6(2): 245-254, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30915626
4.
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA).
RMD Open
; 4(1): e000606, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531787
5.
Defining and characterizing sustained remission in patients with rheumatoid arthritis.
Clin Rheumatol
; 37(4): 885-893, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29224127
6.
Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis.
J Clin Pharmacol
; 58(3): 340-346, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29106714
Resultados
1 -
6
de 6
1
Próxima >
>>